Results 61 to 70 of about 7,963 (219)
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Clinical Endocrinology, EarlyView.ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Joint Pains in Perimenopause/ Menopause
JK Science, 2023 Life expectancy has increased over the time period and thus the proportion of elderly population is rapidly increasing in the developed as well as the developing world. Females live a longer life & are thus more prone to the onslaught of various chronic
Annil Mahajan +2 more
doaj
Journal of Anatomy, EarlyView.We report that femoral cortical thickness was strongly and negatively associated with secondary osteon porosity in an Australian autopsy sample, indicating that thicker cortices contained less porous secondary osteons. This allometric relationship held for the whole sample, males and sedentary well‐nourished individuals, but not for females or other ...
Justyna J. Miszkiewicz +3 more
wiley +1 more source
Research question How does perimenopause affect the prevalence and severity of asthma symptoms in women, considering hormonal fluctuations and potential implications for respiratory health?
Llwyd Orton, Emma Ince
core +3 more sources
Frontiers in NutritionBackgroundPostmenopausal osteoporosis (PMOP) is characterized by high-turnover bone loss and oxidative stress. Astragaloside IV (AS-IV) exhibits antioxidant and immunomodulatory activities, yet its skeletal effects and mechanistic basis in ovariectomized
Ya-Qing Li +11 more
doaj +1 more source
Menopause and vascular endothelial health: Is it all about the oestrogen?
Experimental Physiology, EarlyView.Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Journal of Pharmacy and Bioallied SciencesPerimenopause represents a transitional phase in a woman’s life, marked by significant hormonal and physiological changes that profoundly impact the vaginal milieu.
Megha Tiwari +2 more
doaj +1 more source
Sleep Disturbance and Perimenopause: A Narrative Review [PDF]
Background/Objectives: Perimenopause, impacting 80–90% of women, encompasses a range of vasomotor, urogenital, cognitive, and psychiatric symptoms associated with the fluctuation and gradual reduction of gonadal hormones.
Agnese Immacolata Volpicelli +6 more
core +1 more source
Passive heat intervention research in women: Systematic review and audit of female representation
Experimental Physiology, EarlyView.Abstract Passive heat interventions (PHIs) are non‐exercise heat‐acclimation strategies that improve physiological markers associated with heat tolerance and reduce vulnerability to heat‐related illness, when exercise is not feasible. However, representation of female participants within this literature remains unclear.
Jessica A. Mee +7 more
wiley +1 more source